Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:41:38.256Z.
Calculation as of: 2026-10-06T15:41:38.256Z.
Quote observation: 2026-10-06T15:39:58.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d814f2f9bb590440d28c37f6667649cf2cd18fb847665efd301ef7281cbad61c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$2.73M
EV/FCF Ratio
N/A
TTM Avg
44.01x
3Y Avg
12720.80x
5Y Avg
12720.80x
Market Cap
$2.90M
EV/FCF Ratio
N/A
TTM Avg
97.45x
3Y Avg
2457.89x
5Y Avg
2457.89x
Market Cap
$3.14M
EV/FCF Ratio
N/A
TTM Avg
1500.61x
3Y Avg
1500.61x
5Y Avg
1500.61x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Top KingWin Ltd. Class A (DPU) | $2.79M | N/A | N/A | N/A | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.73M | N/A | 44.01x | 12720.80x | 12720.80x |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.69M | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab Corp. (BGLC)vs › | $2.90M | N/A | 97.45x | 2457.89x | 2457.89x |
| Intelligent Group Limited (INTJ)vs › | $3.10M | N/A | N/A | N/A | N/A |
| PTL Limited (PTLE)vs › | $3.10M | N/A | N/A | N/A | N/A |
| Polar Power, Inc. (POLA)vs › | $3.14M | N/A | 1500.61x | 1500.61x | 1500.61x |
| Iveda Solutions, Inc. (IVDA)vs › | $3.30M | N/A | N/A | N/A | N/A |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.27M | N/A | N/A | N/A | N/A |
| Addentax Group Corp. (ATXG)vs › | $3.36M | N/A | 29.72x | 39.51x | 74.22x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute